RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The Impact of Mood Disorders on the Delivery and Neonatal Outcomes of Methadone-Maintained Pregnant Patients
Tuten, M., Fitzsimons, H., Chisolm, MS., Jones, H., Heil, SH., & O'Grady, KE. (2009). The Impact of Mood Disorders on the Delivery and Neonatal Outcomes of Methadone-Maintained Pregnant Patients. American Journal of Drug and Alcohol Abuse, 35(5), 358-363.
Methadone-maintained pregnant patients with mood disorders have compromised treatment outcomes (1). This study examined the relationship between the presence of mood disorders and delivery and neonatal outcomes. Participants were categorized into two groups: no current mood disorder (n = 30) or primary mood disorder (n = 38). The mood disorder group reported more serious lifetime and current depression than did the no current mood disorder group. Neonates from mothers with mood disorders had a longer length of stay in the neonatal intensive care unit than the no current mood disorder group. Findings emphasize the need to treat mood disorders in methadone-maintained pregnant patients